Estriol (Trimesta) and glatiramer acetate (Copaxone)

A phase II study of a combination of the female hormone and glatiramer acetate (Copaxone) found the combination reduced the relapse rate compare to glatiramer acetate and placebo. The effect in the second year there was still apparent but not statistically significant. Presented at the AAN conference. Health Canal Hormones - A to Z of MS
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news